ANXA13

Across TCGA pan-cancer cohorts, ANXA13 mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ANXA13’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ANXA13 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ANXA13 is over-expressed in tumor, although a few such as COAD and CCRCC show the opposite, repressed pattern.

COAD, CCRCC, and LUAD are the cancer types where ANXA13 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANXA13 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	−0.637	<.001	10	view →
CCRCC	Female	IV	−1.390	.011	1	view →
LUAD	Male	III,IV	−0.315	.015	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ANXA13–COAD

Open the COAD breakdown →